← SynDRA
NVP-BSK805
SynDRA canonical compound SYN0086592 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | JAK2 |
|---|
| Mechanism of action | JAK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALK
- BRD2
- BRD3
- BRD4
- BRDT
- BUB1B
- FLT3
- HDAC6
- JAK1
- RET
- WEE1
Cross-references
Synonyms
- BSK 805
- NVP BSK 805
- MFCD22420810
- DQX
- NVP-BSK 805 HCl
- NVP-BSK805 dihydrochloride?
- SCHEMBL2800994
- SCHEMBL28655676
- SCHEMBL29409512
- C27H28F2N6O
- EX-A286
- IBPVXAOOVUAOKJ-UHFFFAOYSA-N
- BDBM50315231
- AKOS027422657
- CS-1629
- FD43354
- SDCCGSBI-0654389.P001
- NCGC00263202-01
- NCGC00263202-08
- NCGC00263202-10
- AC-28460
- HY-14722
- BRD-K02017404-300-06-2
- BRD-K02017404-300-07-0
- 8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]-2-(1-piperidin-4-yl-1H-pyrazol-4-yl)quinoxaline
- FD146326
- NVP-BSK805 dihydrochloride
- C27H30Cl2F2N6O
- s2686
- NVP-BSK805 2HCl (BSK-805)
- orb1300895
- SCHEMBL23860571
- SW219437-1
- HY-14722A
- DA-47942
- SCHEMBL29378671
- AS-16275
- CCG-264979
- NVP-BSK805 (hydrochloride)
Look up NVP-BSK805 in the interactive SynDRA portal →